Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Infliximab-Dyyb

Brands: Inflectra · Infliximab

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL04AB02
RxCUI (US)191831
US makers1 labelers
Packages1
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.4K6.8K10K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.8K
Rx · 2026 Q1
46K
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 17, 2025
    RECALLRecall (Class II): Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTR…

    cGMP Deviations: Product intended for quarantine was inadvertently distributed. — Recalling firm: McKesson — Nationwide USA